{
  "guideline": {
    "id": "PA166265241",
    "name": "Annotation of DPWG Guideline for clozapine and CYP1A2",
    "relatedChemicals": [
      {
        "id": "PA449061",
        "name": "clozapine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA27093",
        "name": "cytochrome P450 family 1 subfamily A member 2",
        "symbol": "CYP1A2"
      }
    ],
    "source": "DPWG",
    "recommendation": false,
    "guidelineGenes": [],
    "@id": "https://pharmgkb.org/guidelineAnnotation/PA166265241",
    "version": 4
  },
  "annotationGroups": [
    {
      "id": "PA166265301",
      "name": "Normal Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP1A2:Normal function/Normal function",
        "CYP1A2:Normal function/Normal function (CYP1A2*1F)"
      ],
      "metabolizerStatus": {
        "id": 1451698087,
        "html": "<p>CYP1A2 normal metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451698088,
        "html": "<p>The DPWG does not provide a recommendation as there is no gene-drug interaction.</p>\n"
      },
      "implications": {
        "id": 1451698086,
        "html": "<p>This is NOT a gene-drug interaction</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166265281",
      "name": "*1F/*1F",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP1A2:Normal function (CYP1A2*1F)/Normal function (CYP1A2*1F)"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451698023,
        "html": "<p>The guideline does not provide a recommendation for clozapine in patients with the CYP1A2*1F/*1F genotype.</p>\n"
      },
      "implications": {
        "id": 1451698021,
        "html": "<p>The guideline does not provide a description of the impact of the CYP1A2*1F/*1F genotype on clozapine.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166265223",
      "name": "*1C heterozygote",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Possibly",
        "termId": "rxChange:1448602496"
      },
      "genePhenotypes": [
        "CYP1A2:Decreased function/Normal function",
        "CYP1A2:Decreased function/Normal function (CYP1A2*1F)"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451697991,
        "html": "<p>It is not possible to offer substantiated advice for dose reduction based on the literature.</p>\n<ol>\n<li>Adjust the dose as a function of the plasma concentration of clozapine.<br />\nA therapeutic range of 200-600 ng/mL has been proposed for clozapine.</li>\n</ol>\n"
      },
      "implications": {
        "id": 1451697989,
        "html": "<p>The genetic polymorphism can result in a reduced metabolism of clozapine. This can result in an increase in the plasma concentration of clozapine and thereby the risk of adverse events.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166265261",
      "name": "*1C/*1C",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Possibly",
        "termId": "rxChange:1448602496"
      },
      "genePhenotypes": [
        "CYP1A2:Decreased function/Decreased function"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451698005,
        "html": "<p>It is not possible to offer substantiated advice for dose reduction based on the literature.</p>\n<ol>\n<li>Adjust the dose as a function of the plasma concentration of clozapine.<br />\nA therapeutic range of 200-600 ng/mL has been proposed for clozapine.</li>\n</ol>\n"
      },
      "implications": {
        "id": 1451698003,
        "html": "<p>The genetic polymorphism can result in a reduced metabolism of clozapine. This can result in an increase in the plasma concentration of clozapine and thereby the risk of adverse events.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166265302",
      "name": "Intermediate Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP1A2:No function/Normal function",
        "CYP1A2:No function/Normal function (CYP1A2*1F)"
      ],
      "metabolizerStatus": {
        "id": 1451698084,
        "html": "<p>CYP1A2 intermediate metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451698085,
        "html": "<p>The DPWG does not provide a recommendation as there is no gene-drug interaction.</p>\n"
      },
      "implications": {
        "id": 1451698083,
        "html": "<p>This is NOT a gene-drug interaction</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166265321",
      "name": "Poor Metabolizer",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP1A2:Decreased function/No function",
        "CYP1A2:No function/No function"
      ],
      "metabolizerStatus": {
        "id": 1451698081,
        "html": "<p>CYP1A2 poor metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451698082,
        "html": "<p>The DPWG does not provide a recommendation as there is no gene-drug interaction.</p>\n"
      },
      "implications": {
        "id": 1451698080,
        "html": "<p>This is NOT a gene-drug interaction</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": []
}